Reporter brief
RCT of senolytic fisetin combined with biofeedback after meniscus repair in development
What happened
This is a registered randomized clinical trial protocol testing a combined intervention after arthroscopic meniscus repair: oral senolytic fisetin plus a real-time biofeedback program to restore joint loading and return to activity. The study aims to address meniscus injury recovery and reduce posttraumatic osteoarthritis risk in a population with high prevalence of meniscal procedures.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Patients undergoing arthroscopic meniscal repair
- Design
- Rct
- Sample
- —
- Journal
- Austin V Stone
- Published
- May 8, 2025
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.